| Oxidative stress during HIV infection: mechanisms and consequences AV Ivanov, VT Valuev-Elliston, ON Ivanova, SN Kochetkov, ... Oxidative medicine and cellular longevity 2016 (1), 8910396, 2016 | 352 | 2016 |
| HCV and oxidative stress in the liver AV Ivanov, B Bartosch, OA Smirnova, MG Isaguliants, SN Kochetkov Viruses 5 (2), 439-469, 2013 | 242 | 2013 |
| Hepatitis C virus proteins activate NRF2/ARE pathway by distinct ROS-dependent and independent mechanisms in HUH7 cells AV Ivanov, OA Smirnova, ON Ivanova, OV Masalova, SN Kochetkov, ... PloS one 6 (9), e24957, 2011 | 184 | 2011 |
| Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis AV Ivanov, VT Valuev-Elliston, DA Tyurina, ON Ivanova, SN Kochetkov, ... Oncotarget 8 (3), 3895, 2017 | 173 | 2017 |
| Oxidative stress in infection and consequent disease AV Ivanov, B Bartosch, MG Isaguliants Oxidative Medicine and Cellular Longevity 2017, 2017 | 161 | 2017 |
| Luciferase expression allows bioluminescence imaging but imposes limitations on the orthotopic mouse (4T1) model of breast cancer VP Baklaushev, A Kilpeläinen, S Petkov, MA Abakumov, NF Grinenko, ... Scientific reports 7 (1), 7715, 2017 | 125 | 2017 |
| Multigene/multisubtype HIV-1 vaccine induces potent cellular and humoral immune responses by needle-free intradermal delivery A Bråve, K Ljungberg, A Boberg, E Rollman, M Isaguliants, B Lundgren, ... Molecular Therapy 12 (6), 1197-1205, 2005 | 101 | 2005 |
| Topical delivery of imiquimod to a mouse model as a novel adjuvant for human immunodeficiency virus (HIV) DNA AK Zuber, A Bråve, G Engström, B Zuber, K Ljungberg, M Fredriksson, ... Vaccine 22 (13-14), 1791-1798, 2004 | 92 | 2004 |
| HCV core protein uses multiple mechanisms to induce oxidative stress in human hepatoma Huh7 cells AV Ivanov, OA Smirnova, IY Petrushanko, ON Ivanova, IL Karpenko, ... Viruses 7 (6), 2745-2770, 2015 | 81 | 2015 |
| Oncogenic effects of HIV-1 proteins, mechanisms behind M Isaguliants, E Bayurova, D Avdoshina, A Kondrashova, F Chiodi, ... Cancers 13 (2), 305, 2021 | 67 | 2021 |
| Carcinogenesis associated with human papillomavirus infection. Mechanisms and potential for immunotherapy M Vonsky, M Shabaeva, A Runov, N Lebedeva, S Chowdhury, ... Biochemistry (Moscow) 84, 782-799, 2019 | 67 | 2019 |
| Glioblastoma cellular cross-talk converges on NF-κB to attenuate EGFR inhibitor sensitivity C Zanca, GR Villa, JA Benitez, AH Thorne, T Koga, M D'Antonio, ... Genes & development 31 (12), 1212-1227, 2017 | 66 | 2017 |
| Chemically induced oxidative stress increases polyamine levels by activating the transcription of ornithine decarboxylase and spermidine/spermine-N1-acetyltransferase in human … OA Smirnova, MG Isaguliants, MT Hyvonen, TA Keinanen, VL Tunitskaya, ... Biochimie 94 (9), 1876-1883, 2012 | 62 | 2012 |
| Oxidative stress induced by HIV-1 reverse transcriptase modulates the enzyme’s performance in gene immunization M Isaguliants, O Smirnova, AV Ivanov, A Kilpelainen, Y Kuzmenko, ... Human vaccines & immunotherapeutics 9 (10), 2111-2119, 2013 | 54 | 2013 |
| EBV-encoded EBNA-6 binds and targets MRS18-2 to the nucleus, resulting in the disruption of pRb-E2F1 complexes E Kashuba, M Yurchenko, SP Yenamandra, B Snopok, M Isaguliants, ... Proceedings of the National Academy of Sciences 105 (14), 5489-5494, 2008 | 54 | 2008 |
| Hepatitis C virus core protein transforms murine fibroblasts by promoting genomic instability IS Smirnova, ND Aksenov, EV Kashuba, P Payakurel, VV Grabovetsky, ... Analytical Cellular Pathology 28 (4), 177-190, 2006 | 44 | 2006 |
| The successful immune response against hepatitis C nonstructural protein 5A (NS5A) requires heterologous DNA/protein immunization OV Masalova, EI Lesnova, AV Pichugin, TM Melnikova, VV Grabovetsky, ... Vaccine 28 (8), 1987-1996, 2010 | 43 | 2010 |
| Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost … E Alekseeva, I Sominskaya, D Skrastina, I Egorova, E Starodubova, ... Genetic vaccines and therapy 7, 1-17, 2009 | 43 | 2009 |
| The rationale behind a vaccine based on multiple HIV antigens E Rollman, A Bråve, A Boberg, L Gudmundsdotter, G Engström, ... Microbes and infection 7 (14), 1414-1423, 2005 | 41 | 2005 |
| DNA-encoding enzymatically active HIV-1 reverse transcriptase, but not the inactive mutant, confers resistance to experimental HIV-1 challenge MG Isaguliants, NN Petrakova, B Zuber, K Pokrovskaya, R Gizatullin, ... Intervirology 43 (4-6), 288-293, 2001 | 36 | 2001 |
